ATAI Life Sciences
ATAI
ATAI
97 hedge funds and large institutions have $74.2M invested in ATAI Life Sciences in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 36 increasing their positions, 11 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3.72% more ownership
Funds ownership: 9.74% → 13.46% (+3.7%)
7% less capital invested
Capital invested by funds: $79.4M → $74.2M (-$5.24M)
Holders
97
Holding in Top 10
–
Calls
$1.72M
Puts
$460K
Top Buyers
| 1 | +$4.8M | |
| 2 | +$4.42M | |
| 3 | +$2.56M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.75M |
| 5 |
Morgan Stanley
New York
|
+$1.3M |
Top Sellers
| 1 | -$2.02M | |
| 2 | -$1.59M | |
| 3 | -$1.4M | |
| 4 |
AC
Antara Capital
New York
|
-$1.31M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$1.31M |